BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Microsoft
MSFT
|
+$906M |
| 3 |
Visa
V
|
+$730M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$720M |
| 5 |
Amazon
AMZN
|
+$540M |
Top Sells
| 1 |
Apple
AAPL
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$306M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$214M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$203M |
| 5 |
Bank of America
BAC
|
+$153M |
Sector Composition
| 1 | Technology | 27.67% |
| 2 | Consumer Discretionary | 10.07% |
| 3 | Financials | 9.77% |
| 4 | Healthcare | 9.61% |
| 5 | Communication Services | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Mesa Laboratories
MLAB
$339M
| $351K | ﹤0.01% |
4,046
-3,519
| -47% | -$305K |
|
2052
BioXcel Therapeutics
BTAI
$49.8M
| $350K | ﹤0.01% |
17,071
+15,712
| +1,156% | +$322K |
|
|
AGS
2053
DELISTED
PlayAGS
AGS
| $348K | ﹤0.01% |
30,280
-20,236
| -40% | -$233K |
|
2054
Conduent
CNDT
$445M
| $347K | ﹤0.01% |
106,547
-36,837
| -26% | -$120K |
|
2055
Kelly Services Class A
KELYA
$481M
| $345K | ﹤0.01% |
16,128
-6,448
| -29% | -$138K |
|
2056
Lindblad Expeditions
LIND
$735M
| $345K | ﹤0.01% |
35,778
+18,420
| +106% | +$178K |
|
2057
Johnson Outdoors
JOUT
$422M
| $344K | ﹤0.01% |
9,837
+6,662
| +210% | +$233K |
|
2058
Commerce Bancshares
CBSH
$7.95B
| $344K | ﹤0.01% |
6,476
-6,388
| -50% | -$339K |
|
2059
Universal Technical Institute
UTI
$1.48B
| $344K | ﹤0.01% |
21,845
-23,594
| -52% | -$371K |
|
2060
LSI Industries
LYTS
$686M
| $342K | ﹤0.01% |
23,638
+2,393
| +11% | +$34.6K |
|
2061
Evolus
EOLS
$465M
| $341K | ﹤0.01% |
31,448
-374,483
| -92% | -$4.06M |
|
2062
Daktronics
DAKT
$1.14B
| $340K | ﹤0.01% |
24,338
-11,286
| -32% | -$157K |
|
|
IBTX
2063
DELISTED
Independent Bank Group, Inc.
IBTX
| $339K | ﹤0.01% |
7,451
-11,165
| -60% | -$508K |
|
2064
NewMarket
NEU
$7.87B
| $338K | ﹤0.01% |
656
-743
| -53% | -$383K |
|
|
WSR
2065
Whitestone REIT
WSR
$664M
| $338K | ﹤0.01% |
25,376
+681
| +3% | +$9.06K |
|
2066
BridgeBio Pharma
BBIO
$9.79B
| $337K | ﹤0.01% |
13,301
-124,643
| -90% | -$3.16M |
|
2067
Cerus
CERS
$236M
| $337K | ﹤0.01% |
191,420
-27,227
| -12% | -$47.9K |
|
2068
Ooma
OOMA
$345M
| $336K | ﹤0.01% |
33,845
-22,351
| -40% | -$222K |
|
2069
Orthofix Medical
OFIX
$589M
| $336K | ﹤0.01% |
25,302
-9,300
| -27% | -$123K |
|
2070
Organogenesis Holdings
ORGO
$625M
| $335K | ﹤0.01% |
119,562
-3,824
| -3% | -$10.7K |
|
2071
Surmodics
SRDX
$457M
| $334K | ﹤0.01% |
7,949
+1,071
| +16% | +$45K |
|
2072
ORIX
IX
$30B
| $334K | ﹤0.01% |
15,005
-4,000
| -21% | -$89K |
|
|
XHR
2073
Xenia Hotels & Resorts
XHR
$1.41B
| $332K | ﹤0.01% |
23,160
-31,655
| -58% | -$454K |
|
2074
Quanterix
QTRX
$224M
| $332K | ﹤0.01% |
25,118
-12,595
| -33% | -$166K |
|
2075
Central Garden & Pet
CENT
$2.24B
| $331K | ﹤0.01% |
8,596
+2,427
| +39% | +$93.4K |
|